will tirzepatide go back on shortage list FDA says the weight-loss drug is over Eli Lilly sues companies selling

2 Transformative therapeutics Lotte Bjerre Knudsens work at Novo Nordisk marked a pivotal transition from scientific discovery to clinical application

It is a challenge to predict the individual response to GLP-1RAs through accurate medical treatment and optimize the treatment plan accordingly

Anal fissures can cause pain during and immediately after a bowel movement and bleeding from the anus

As both of these expanded indications are related to the medications' weight loss outcomes, coverage still depends on a payer's decision to cover weight loss medications

Working with telehealth providers Many patients access Empower tirzepatide through telehealth platforms that have established relationships with the pharmacy